Please use this identifier to cite or link to this item: http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/9687
Full metadata record
DC FieldValueLanguage
dc.contributor.authorManilgama, S. R.-
dc.contributor.authorHettiarachchi, N.M.-
dc.contributor.authorJayasinghe, K.I.-
dc.contributor.authorDe Silva, S.-
dc.contributor.authorWanigaratne, T.-
dc.contributor.authorJayalath, T.-
dc.contributor.authorBandusiri, R.P.-
dc.contributor.authorSuganthan, N.-
dc.date.accessioned2023-09-19T03:43:14Z-
dc.date.available2023-09-19T03:43:14Z-
dc.date.issued2021-
dc.identifier.citationManilgama, S. R., Hettiarachchi, N. M., Jayasinghe, K. I., De Silva, S., Wanigaratne, T., Jayalath, T., ... & Kulaweera, M. T. D. (2022). Prevalence of covishield COVID-19 vaccine (chadox1 ncov-19) adverse effects among health care workers in sri lanka. International Journal of Infectious Diseases, 116, S61.en_US
dc.identifier.urihttp://repo.lib.jfn.ac.lk/ujrr/handle/123456789/9687-
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectCOVID-19en_US
dc.subjectCovishield Vaccineen_US
dc.titlePrevalence of Covishield COVID-19 Vaccine (ChAdOx1 nCoV-19) Adverse Effects among Health Care Workers in Sri Lankaen_US
dc.typeArticleen_US
Appears in Collections:Medicine

Files in This Item:
File Description SizeFormat 
Prevalence of Covishield COVID-19 Vaccine.pdf138.41 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.